Calme, Jasky .
HRN: 22-99-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2023
CEFUROXIME 750MG (VIAL)
04/30/2023
05/07/2023
IV
750 Mg
Q8hrs
Open Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes